Dr. Indu Ramachandra Rao

Associate Professor

Department of Nephrology

Qualification: MBBS ,MD, DM Nephrology

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    • Teaching undergraduates, postgraduates, DM residents
    • Thesis guide for DM residents
    • PhD co-guide

SUBJECTS CURRENTLY TEACHING

Subject Semester / Year
Nephrology

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
MD Internal Medicine Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh December 2012
DM Nephrology Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh December 2016

Experience

Institution / Organisation Designation Role Tenure
KMC Manipal Associate Professor October 2019 - till date
KMC Manipal Assistant Professor January 2017-October 2019
Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh Senior Resident (Internal Medicine) January 2013-September 2013

Role of remote ischaemic conditioning in prevention of contrast induced nephropathy following percutaneous coronary intervention: a randomised controlled trial

Principal Investigator: Dr. Indu Ramachandra Rao

Co-investigator: Dr. Ganesh Paramasivam, Dr. Ravindra Prabhu, Dr. Shankar Prasad Nagaraju, Dr. Tom Devasia

Funding agencies: ICMR

Brief overview: Remote ischaemic conditioning (RIC) is a technique in which brief periods of ischaemia in a remote vascular bed provides protection against prolonged ischaemia in a distant (target) organ.

-It is a non-invasive, non-pharmacological, safe and virtually cost-free novel technique.

-This study aims to study the effect of RIC on renal outcomes in patients undergoing percutaneous coronary intervention.

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Glomerular diseases, chronic kidney disease, acute kidney injury

Area of Expertise

Interventional nephrology, glomerular diseases

Area of Research

Clinical nephrology: Acute kidney injury, chronic kidney disease, glomerular diseases

Professional Affiliations & Contributions

Member of International Society of Nephrology, ERA-EDTA, Women in Nephrology, Indian Society of Nephrology, Indian Society of Organ Transplantation, Association of Vascular Access and Interventional Renal Physicians (AVATAR)

CD19 TARGETED RITUXIMAB THERAPY IN ADULT CALCINEURIN INHIBITOR RESISTANT,DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS

2016-01-01 Harbir Singh Kohli Raja Ramachandran Indu R Rao Ritambhra Nada Krishan Lal L. Gupta

J Am Soc Nephrol. 2016;27: 775A-776A

RITUXIMAB IS AN EFFECTIVE THERAPY FOR CALCINEURIN INHIBITOR RESISTANT/DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ADULTS.

2016-01-01 Indu R Rao Harbir S Kohli Raja Ramachandran K.L. Gupta Ranjana W. Minz

Nephrol Dial Transpl.2016;31(suppl 1): i126-42